Responsiveness to cetuximab without mutations in EGFR

N Engl J Med. 2005 Jul 14;353(2):208-9. doi: 10.1056/NEJM200507143530218.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / genetics*
  • Drug Resistance, Neoplasm / genetics
  • ErbB Receptors / genetics*
  • Humans
  • Mutation*
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • ErbB Receptors
  • Cetuximab